EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Revisiting Coley’s Toxins: Immunogenic Cardiolipins from Streptococcus pyogenes

Yern-Hyerk Shin, Sunghee Bang iD, Sung-Moo Park, Xiao Ma, Chelsi Cassilly, Daniel Graham, Ramnik Xavier, Jon Clardy iD

Journal of the American Chemical Society · 04.10.2023 · 145 (39) · 21183-21188

DOI: 10.1021/jacs.3c07727 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 22.09.2023. Verfasst von Yern-Hyerk Shin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School and Blavatnik Institute, Boston, Massachusetts 02115, United St…. Hauptthemen laut MEDLINE: Streptococcus pyogenes, Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NIAID NIH HHS, NCCIH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coley's toxins, an early and enigmatic form of cancer (immuno)therapy, were based on preparations of Streptococcus pyogenes. As part of a program to explore bacterial metabolites with immunomodulatory potential, S. pyogenes metabolites were assayed in a cell-based immune assay, and a single membrane lipid, 18:1/18:0/18:1/18:0 cardiolipin, was identified. Its activity was profiled in additional cellular assays, which showed it to be an agonist of a TLR2-TLR1 signaling pathway with a 6 μM EC50 and robust TNF-α induction. A synthetic analog with switched acyl chains had no measurable activity in immune assays. The identification of a single immunogenic cardiolipin with a restricted structure-activity profile has implications for immune regulation, cancer immunotherapy, and poststreptococcal autoimmune diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Streptococcus pyogenesNeoplasmsHumansCardiolipinsTumor Necrosis Factor-alpha

Substanzen

CardiolipinsTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School and Blavatnik Institute, Boston, Massachusetts 02115, United States.
  • Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, United States.
  • Department of Molecular Biology and Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.

ORCID-Profile: Sunghee Bang, Jon Clardy

Förderung

  • NIDDK NIH HHS
  • NIAID NIH HHS
  • NCCIH NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Shin, Y. H., Bang, S., Park, S. M., Ma, X., Cassilly, C., Graham, D., Xavier, R., & Clardy, J. (2023). Revisiting Coley’s Toxins: Immunogenic Cardiolipins from Streptococcus pyogenes. Journal of the American Chemical Society, 145(39), 21183-21188. https://doi.org/10.1021/jacs.3c07727

Vancouver

Shin YH, Bang S, Park SM, Ma X, Cassilly C, Graham D, et al. Revisiting Coley’s Toxins: Immunogenic Cardiolipins from Streptococcus pyogenes. Journal of the American Chemical Society. 2023;145(39):21183-21188. doi:10.1021/jacs.3c07727

BibTeX
@article{Shin2023,
  author = {Shin, Yern-Hyerk and Bang, Sunghee and Park, Sung-Moo and Ma, Xiao and Cassilly, Chelsi and Graham, Daniel and Xavier, Ramnik and Clardy, Jon},
  title = {Revisiting Coley’s Toxins: Immunogenic Cardiolipins from Streptococcus pyogenes},
  journal = {Journal of the American Chemical Society},
  year = {2023},
  volume = {145},
  number = {39},
  pages = {21183--21188},
  doi = {10.1021/jacs.3c07727}
}
Kostenlos starten →